Seattle volunteers who got shots in the first trial of a possible coronavirus vaccine are now getting the second shot — an indicator the early trial is progressing well.
The
The vaccine, called mRNA-1273, was developed by scientists at the National Institute of Allergy and Infectious Diseases and at the Cambridge, Mass.-based biotechnology company Moderna, Inc.. The second shot, administered 28 days later, builds on that protection so the body can more rapidly produce antibodies if it is later exposed to the virus.
The experimental Moderna vaccine uses messenger RNA to get the body’s own cells to produce a protein found on the “spikes” on the surface of the SARS-CoV-2 virus it uses to infect human cells.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
I'm A Doctor In A COVID-19 Unit. Here's One Vital Step I Wish Everyone Would Take.'While we are social distancing in our homes, it’s time to have that conversation that most of us have avoided ― or didn’t even know we needed to have.'
Read more »
Germany approves trials of COVID-19 vaccine candidateGermany gave the green light for human trials of potential coronavirus vaccines developed by German biotech company BioNTech, which is racing teams in Germany, the U.S. and China to develop an agent that will stop the pandemic.
Read more »
Two Pet Cats In New York Have Tested Positive For The CoronavirusOne of the owners had tested positive for COVID-19 before their cat started showing symptoms.
Read more »
FBI sees cybercrime reports increase fourfold during COVID-19 outbreakCybercrime has increased since the start of the COVID-19 pandemic.
Read more »